A daily updated 'Due Diligence' service assessing the impact of protein research on drug R&D

The explosion in information on protein systems and their involvement in disease has created a new challenge for those involved in drug R&D - how to identify, and act on, the information that's really crucial from the drug industry's perspective.

There is a clear need to gather, filter and critically evaluate this mass of information so that it can be used by executives working within Research Portfolio Management, Strategic Planning, Competitor Intelligence, Business Development & Licensing and R&D departments to identify new opportunities and threats emerging from ground-breaking research in molecular and systems biology.

In order to perform 'due diligence' on external protein target research activities, TIS combines several unique features:

Daily Case Reports - written by internal editors with external experts' comments, these provide rapid identification and analysis of the newly published findings mostly likely to impact drug target selection, drug target validation and a company's resulting drug research strategy

The Diligence Reports - a rolling 100-day analysis of events providing a quantitative and qualitative perspective on emergent biology, competitor activities and potential collaborators

The Targeted Protein Database (TPdb) - covering the entire human proteome and underlying TIS, the TPdb provides detailed, structured information gathered about each protein which is consolidated within the following TIS Reports:

TIS Proteins & Targets Report
Provides a full TPdb/Swiss-Prot description of each protein and details about all the diseases and institutes associated with the target plus a list of recent references and patents

TIS Diseases & Disorders Report
Consolidated around each disease/disorder, this report provides an overview of all proteins associated with each disease, listing all the recent manually curated references associating the disease with named proteins

TIS Drug & Biologics Report
Optionally includes links to commercial drug pipeline databases for further details

 TIS Business & Strategy Reports
Consolidated around any institute, commercial or academic, involved in specified target research, this report lists all targets associated with each institution plus a list of recent target-related references and patents

Conference Reports
Coverage of approximately 100 target-oriented conferences each year by attending expert scientists and daily overnight reports by Current BioData staff scientists, focusing on data presented that further knowledge of the role of proteins in disease and their potential as drug targets.

 

 

 

Find out more
If you would like to find out more about the Target Intelligence Service (TIS) please fill in your details below and we will contact you directly.

If you are interested in getting your company involved in the TIS Partnered Trial Program, please contact Mr Jim Jacketti, SVP New Business Development at jim.jacketti@currentbiodata.com

For more information download the TIS Partnered Trial Program PDF.